Full Text View
Tabular View
No Study Results Posted
Related Studies
Clopidogrel PGX Bench to Bedside (PGXB2B)
This study has been completed.
Study NCT01341600   Information provided by University of Maryland

First Received on April 22, 2011.   Last Updated on September 28, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metabolism of Clopidogrel
Interventions listed in this trial
Clopidogrel, Omeprazole
Additional drug interventions recognized in this trial
Clopidogrel
Omeprazole
Ticlopidine
More general drug interventions related to this trial
Anti-Ulcer Agents
Cardiovascular Agents
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Gastrointestinal Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Purinergic Agents
Purinergic Antagonists
Purinergic P2 Receptor Antagonists
Purinergic P2Y Receptor Antagonists
Therapeutic Uses
Sponsors listed in this trial
University of Maryland
Food and Drug Administration (FDA)
National Cancer Institute (NCI)
National Institute of General Medical Sciences (NIGMS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services